Merck’s Clark on PR Woes: ‘I Can’t Blame the Media’

Merck CEO Richard Clark has taken some hard knocks since the results of the Enhance study raised questions about the effectiveness of cholesterol drugs Vytorin and Zetia. At a Morgan Stanley conference today, Clark was asked about all the bad press the company has been getting: Is Merck not providing the positive stories or are [...]